Proteinase-activated receptor-2 (PAR2) agonist causes periodontitis in rats
Contribuinte(s) |
Universidade Estadual Paulista (UNESP) |
---|---|
Data(s) |
27/05/2014
27/05/2014
01/02/2005
|
Resumo |
Proteinase-activated receptor-2 (PAR2) is a G-protein-coupled receptor that mediates cellular responses to extracellular proteinases. Since PAR2 is expressed by oral epithelial cells, osteoblasts, and gingival fibroblasts, where its activation releases interleukin-8, we hypothesized that PAR2 activation may participate in periodontal disease in vivo. We investigated the role of PAR2 activation in periodontal disease in rats. Radiographic and enzymatic (myeloperoxidase) analysis revealed that topical application of PAR2 agonist causes periodontitis but also exacerbates existing periodontitis, leading to significant alveolar bone loss and gingival granulocyte infiltration. Inhibition of matrix metalloproteinase (MMP) and cyclo-oxygenase (COX) decreased PAR2 agonist-induced periodontitis. More specifically, the overexpression of COX-1, COX-2, MMP-2, and MMP-9 in gingival tissues suggests that they are involved in PAR 2-induced periodontitis. In conclusion, PAR2 agonist causes periodontitis in rats through a mechanism involving prostaglandin release and MMP activation. Inhibition of PAR2 may represent a novel approach to modulate host response in periodontitis. |
Formato |
154-159 |
Identificador |
http://dx.doi.org/10.1177/154405910508400209 Journal of Dental Research, v. 84, n. 2, p. 154-159, 2005. 0022-0345 http://hdl.handle.net/11449/68126 10.1177/154405910508400209 WOS:000226834200009 2-s2.0-15544371471 |
Idioma(s) |
eng |
Relação |
Journal of Dental Research |
Direitos |
closedAccess |
Palavras-Chave | #Alveolar bone loss #Cyclo-oxygenase #Inflammation #Matrix metalloproteinase #Periodontitis #Proteinase-activated receptor-2 #enzyme inhibitor #matrix metalloproteinase #oligopeptide #prostaglandin synthase #proteinase activated receptor 2 #seryl leucyl isoleucyl glycyl arginyl leucinamide #seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide #analysis of variance #animal #chemically induced disorder #comparative study #drug effect #drug potentiation #gingiva #granulocyte #immunology #male #metabolism #osteolysis #periodontitis #randomization #rat #Wistar rat #Alveolar Bone Loss #Analysis of Variance #Animals #Enzyme Inhibitors #Gingiva #Granulocytes #Male #Matrix Metalloproteinases #Oligopeptides #Prostaglandin-Endoperoxide Synthases #Random Allocation #Rats #Rats, Wistar #Receptor, PAR-2 |
Tipo |
info:eu-repo/semantics/article |